Report of consensus panel 5 from the 11th international workshop on Waldenstrom's macroglobulinemia on COVID-19 prophylaxis and management

Consensus Panel 5 (CP5) of the 11th International Workshop on Waldenstrom's Macroglobulinemia (IWWM-11; held in October 2022) was tasked with reviewing the current data on the coronavirus disease-2019 (COVID-19) prophylaxis and management in patients with Waldenstrom's Macroglobulinemia (W...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Seminars in hematology 2023-03, Vol.60 (2), p.107-112
Hauptverfasser:	Terpos, E., Branagan, A.R., García-Sanz, R., Trotman, J., Greenberger, L.M., Stephens, D.M., Morel, P., Kimby, E., Frustaci, A.M., Hatjiharissi, E., San-Miguel, J., Dimopoulos, M.A., Treon, S.P., Leblond, V.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral Agents - therapeutic use BNT162b2 Consensus COVID-19 COVID-19 Vaccines Humans Life Sciences mRNA-1273 SARS-CoV-2 Vaccine Waldenstrom Macroglobulinemia - diagnosis Waldenstrom Macroglobulinemia - drug therapy Waldenstrom Macroglobulinemia - prevention & control Waldenstrom's Macroglobulinemia
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!